These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 1576632

  • 1. Efficacy of two comparative antibiotic regimens in the treatment of serious intra-abdominal infections: results of a multicenter study.
    Eckhauser FE, Knol JA, Raper SE, Mulholland MW, Helzerman P.
    Clin Ther; 1992; 14(1):97-109. PubMed ID: 1576632
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Randomized comparative trial of imipenem/cilastatin versus aminoglycoside plus amoxycillin plus clindamycin in the treatment of severe intra- and post-operative infections.
    Cakmakci M, Stern A, Schilling J, Christen D, Roggo A, Geroulanos S.
    Drugs Exp Clin Res; 1993; 19(5):223-7. PubMed ID: 8174495
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and tolerability of imipenem-cilastatin versus clindamycin+gentamicin for serious pelvic infections.
    Larsen JW, Gabel-Hughes K, Kreter B.
    Clin Ther; 1992; 14(1):90-6. PubMed ID: 1576631
    [Abstract] [Full Text] [Related]

  • 5. Postpartum endometritis: efficacy and tolerability of two antibiotic regimens.
    Gonik B.
    Clin Ther; 1992; 14(1):83-9. PubMed ID: 1576630
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A randomized prospective study of cefepime plus metronidazole with imipenem-cilastatin in the treatment of intra-abdominal infections.
    Garbino J, Villiger P, Caviezel A, Matulionyte R, Uckay I, Morel P, Lew D.
    Infection; 2007 Jun; 35(3):161-6. PubMed ID: 17565457
    [Abstract] [Full Text] [Related]

  • 8. Imipenem/cilastatin versus aminoglycoside plus amoxicillin plus clindamycin in the treatment of serious postoperative infections.
    Christen D, Buchmann P, Geroulanos S.
    Scand J Infect Dis Suppl; 1987 Jun; 52():11-4. PubMed ID: 3331039
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparison of imipenem/cilastatin with the combination of aztreonam and clindamycin in the treatment of intra-abdominal infections.
    de Groot HG, Hustinx PA, Lampe AS, Oosterwijk WM.
    J Antimicrob Chemother; 1993 Sep; 32(3):491-500. PubMed ID: 8262872
    [Abstract] [Full Text] [Related]

  • 11. Multicenter randomized trial comparing meropenem (1.5 g daily) and imipenem/cilastatin (2 g daily) in the hospital treatment of community-acquired pneumonia.
    Bartoloni A, Strohmeyer M, Corti G, Buonomini MI, Franchino L, Romanelli G, Moretti AM, De Vizzi GB, Petraglia A, Mancini P, Atzeni R, Fogliani V, Giura R, Paradisi F.
    Drugs Exp Clin Res; 1999 Sep; 25(6):243-52. PubMed ID: 10713862
    [Abstract] [Full Text] [Related]

  • 12. Meropenem versus imipenem/cilastatin in the treatment of sepsis in Chinese patients.
    Kuo BI, Fung CP, Liu CY.
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 May; 63(5):361-7. PubMed ID: 10862445
    [Abstract] [Full Text] [Related]

  • 13. Oral clindamycin 300 mg BID compared with oral amoxicillin/clavulanic acid 1 g BID in the outpatient treatment of acute recurrent pharyngotonsillitis caused by group a beta-hemolytic streptococci: an international, multicenter, randomized, investigator-blinded, prospective trial in patients between the ages of 12 and 60 years.
    Mahakit P, Vicente JG, Butt DI, Angeli G, Bansal S, Zambrano D.
    Clin Ther; 2006 Jan; 28(1):99-109. PubMed ID: 16490583
    [Abstract] [Full Text] [Related]

  • 14. Therapeutic equivalence of generic imipenem/cilastatin for therapy of infections at Siriraj Hospital.
    Piyasirisilp S, Premprawat W, Thamlikitkul V.
    J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S117-25. PubMed ID: 20364566
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: a phase III, prospective, multicenter, randomized, double-blind, noninferiority study.
    Lucasti C, Jasovich A, Umeh O, Jiang J, Kaniga K, Friedland I.
    Clin Ther; 2008 May; 30(5):868-83. PubMed ID: 18555934
    [Abstract] [Full Text] [Related]

  • 17. Results of the North American trial of piperacillin/tazobactam compared with clindamycin and gentamicin in the treatment of severe intra-abdominal infections. Investigators of the Piperacillin/Tazobactam Intra-abdominal Infection Study Group.
    Eur J Surg Suppl; 1994 May; (573):61-6. PubMed ID: 7524798
    [Abstract] [Full Text] [Related]

  • 18. Imipenem/cilastatin therapy for serious infections in neonates and infants.
    Nalin DR, Jacobsen CA.
    Scand J Infect Dis Suppl; 1987 May; 52():46-55. PubMed ID: 3331042
    [Abstract] [Full Text] [Related]

  • 19. Imipenem/cilastatin versus amikacin plus piperacillin in the treatment of infections in neutropenic patients: a prospective, randomized multi-clinic study.
    Norrby SR, Vandercam B, Louie T, Runde V, Norberg B, Anniko M, Andrien F, Baudrihaye M, Bow E, Burman LA.
    Scand J Infect Dis Suppl; 1987 May; 52():65-78. PubMed ID: 3331044
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and tolerability of imipenem-cilastatin versus ceftazidime plus tobramycin as empiric therapy of presumed bacterial infection in neutropenic cancer patients.
    Miller JA, Butler T, Beveridge RA, Kales AN, Binder RA, Smith LJ, Ueno WM, Milkovich G, Goldwater S, Marion A.
    Clin Ther; 1993 May; 15(3):486-99. PubMed ID: 8364941
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.